{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:02:37Z","timestamp":1792674157046,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.sleep.2010.07.007","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T07:11:31Z","timestamp":1283584291000},"page":"807-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Restless legs syndrome: Understanding its consequences and the need for better treatment"],"prefix":"10.1016","volume":"11","author":[{"given":"Christopher J.","family":"Earley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Silber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2010.07.007_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.870120111","article-title":"Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria","volume":"12","author":"Montplaisir","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ana.410410513","article-title":"Cerebral generators involved in the pathogenesis of the restless legs syndrome","volume":"41","author":"Bucher","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0020","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/21.4.381","article-title":"Iron and the restless legs syndrome","volume":"21","author":"Sun","year":"1998","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0030","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/ajmg.a.33087","article-title":"The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome","volume":"149A","author":"Caylak","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.sleep.2010.07.007_b0035","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact. REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0040","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.WNL.0000163996.64461.A3","article-title":"Restless legs syndrome: a community-based study of prevalence, severity and risk factors","volume":"64","author":"Hogl","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/01.wnl.0000168910.48309.4a","article-title":"Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT study","volume":"65","author":"Tison","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0050","first-page":"739","article-title":"Restless legs syndrome and sleep bruxism: prevalence and association among Canadians","volume":"17","author":"Lavigne","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0055","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/archinte.163.19.2323","article-title":"Restless legs syndrome symptoms in primary care. A prevalence study","volume":"163","author":"Nichols","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1378\/chest.129.1.76","article-title":"Prevalence and correlates of restless legs syndrome. Results from the 2005 National Sleep Foundation poll","volume":"129","author":"Phillips","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2010.07.007_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sleep.2009.03.007","article-title":"Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in Western Europe: prevalence and characteristics","volume":"11","author":"Allen","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0149-2918(04)90136-1","article-title":"Evaluating the quality of life of patients with restless legs syndrome","volume":"26","author":"Abetz","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2010.07.007_b0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archinte.164.2.196","article-title":"Sex and the risk of restless legs syndrome in the general population","volume":"164","author":"Berger","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11136-006-9142-8","article-title":"Burden of restless legs syndrome on health-related quality of life","volume":"16","author":"Kushida","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1016\/j.sleep.2010.07.007_b0090","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.genm.2009.12.001","article-title":"Health-related quality of life in Swedish men and women with early rheumatoid arthritis","volume":"6","author":"West","year":"2009","journal-title":"Gender Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0404.2009.01245.x","article-title":"Is there a need for long-term follow-up in chronic idiopathic polyneuropathy?","volume":"120","author":"Rudolph","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.sleep.2010.07.007_b0105","first-page":"891","article-title":"Restless legs syndrome, periodic limb movements in sleep, and depression","volume":"28","author":"Picchietti","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/11317500-000000000-00000","article-title":"Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management","volume":"24","author":"Hornyak","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2010.07.007_b0115","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.54.5.1064","article-title":"Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly","volume":"54","author":"Rothdach","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1440-1819.2003.01115.x","article-title":"Sleep disturbances and depression in the elderly in Japan","volume":"57","author":"Sukegawa","year":"2003","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.sleep.2010.07.007_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00415-005-0604-7","article-title":"\u201cAnxietas tibiarum\u201d. Depression and anxiety disorders in patients with restless legs syndrome","volume":"252","author":"Winkelmann","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/mds.1209","article-title":"Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms","volume":"16","author":"Ulfberg","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3999(02)00443-9","article-title":"Prevalence of restless legs syndrome and periodic limb movement disorder in the general population","volume":"53","author":"Ohayon","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.sleep.2010.07.007_b0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.sleep.2006.01.004","article-title":"Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort","volume":"7","author":"Winkelman","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1212\/01.wnl.0000287072.93277.c9","article-title":"Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study","volume":"70","author":"Winkelman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0150","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/01.wnl.0000259036.89411.52","article-title":"Nocturnal blood pressure changes in patients with restless legs syndrome","volume":"68","author":"Pennestri","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/sleep\/32.5.589","article-title":"Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke","volume":"32","author":"Walters","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.21261","article-title":"Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study)","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0165","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2010.07.007_b0170","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double blind, randomized parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0175","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/01.wnl.0000231513.23919.a1","article-title":"Efficacy and safety of pramipexole in restless legs syndrome","volume":"67","author":"Winkelman","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0180","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archneur.61.9.1393","article-title":"Long-term treatment of restless legs syndrome with dopamine agonists","volume":"61","author":"Ondo","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/sleep\/26.7.819","article-title":"Pramipexole in the management of restless legs syndrome: an extended study","volume":"26","author":"Silber","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0190","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1468-1331.2006.01459.x","article-title":"Long-term treatment with pramipexole in restless legs syndrome","volume":"13","author":"Montplaisir","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0195","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/sleep\/27.5.907","article-title":"Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome","volume":"27","author":"Allen","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0200","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.55.10.1589","article-title":"Safety of pramipexole in patients with restless legs syndrome","volume":"55","author":"Stiasny","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0205","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.sleep.2007.03.022","article-title":"Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute","volume":"8","author":"Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0210","doi-asserted-by":"crossref","unstructured":"Garcia-Borreguero D, Williams A. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev 2010. doi:10.1016\/j.smrv.2009.11.006.","DOI":"10.1016\/B978-075067518-5.10013-8"},{"key":"10.1016\/j.sleep.2010.07.007_b0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0220","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00415-009-5299-8","article-title":"Progressive development of augmentation during long term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study","volume":"257","author":"Hogl","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0225","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1389-9457(02)00144-2","article-title":"Restless legs syndrome augmentation and pramipexole treatment","volume":"3","author":"Ferini-Strambi","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2003.07.005","article-title":"Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)","volume":"5","author":"Winkelman","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.sleep.2008.09.007","article-title":"The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels","volume":"10","author":"Frauscher","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.sleep.2007.07.020","article-title":"Augmentation in restless legs syndrome is associated with low ferritin","volume":"9","author":"Trenkwalder","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0245","first-page":"A253","article-title":"Augmentation with pramipexole in the long-term treatment of restless legs syndrome","volume":"25","author":"Winkelman","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0250","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0255","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0025-6196(11)60538-7","article-title":"Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease","volume":"84","author":"Bostwick","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2010.07.007_b0260","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mds.21303","article-title":"Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis","volume":"22","author":"Evans","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0265","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2006.10.001","article-title":"Pathological gambling associated with dopamine agonist use in restless legs syndrome","volume":"13","author":"Quickfall","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/sleep\/32.5.587","article-title":"A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist","volume":"32","author":"Salas","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","article-title":"Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome","volume":"30","author":"Driver-Dunkley","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2010.07.007_b0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","article-title":"Predictors of impulsivity and reward seeking behavior with dopamine agonists","volume":"14","author":"Ondo","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0285","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0290","doi-asserted-by":"crossref","unstructured":"Cilia R, Ko JH, Cho SS, et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis 2010. doi:10.1016\/j.nbd.2010.03.013.","DOI":"10.1016\/j.nbd.2010.03.013"},{"key":"10.1016\/j.sleep.2010.07.007_b0295","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.20251","article-title":"Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study","volume":"19","author":"Stiasny-Kolster","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0300","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archneur.65.12.1604","article-title":"Functional abnormalities underlying pathological gambling in Parkinson disease","volume":"65","author":"Cilia","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0305","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/brain\/awp170","article-title":"At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists","volume":"132","author":"Abler","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2010.07.007_b0310","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2010.07.007_b0315","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/sleep\/27.3.560","article-title":"An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review","volume":"27","author":"Hening","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0320","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.21225","article-title":"Valvular heart disease in Parkinson\u2019s disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study","volume":"22","author":"Junghanns","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Eng J Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0330","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/01.wnl.0000238508.68593.1d","article-title":"Dopamine agonists and cardiac valvulopathy in Parkinson disease. A case-control study","volume":"67","author":"Yamamoto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0335","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1474-4422(08)70112-1","article-title":"Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Trenkwalder","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0340","first-page":"A307","article-title":"Augmentation in long-term therapy of the restless legs syndrome with transdermal rotigotine \u2013 a retrospective systematic analysis of two large open-label 1-year trials","volume":"32","author":"Benes","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0345","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/sleep\/16.8.717","article-title":"A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa\/levodopa and propoxyphene","volume":"16","author":"Kaplan","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0350","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/sleep\/16.4.327","article-title":"Succesful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo","volume":"16","author":"Walters","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0355","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Mov Dis"},{"key":"10.1016\/j.sleep.2010.07.007_b0360","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4637.2007.00343.x","article-title":"Sleep-disordered breathing and chronic opioid therapy","volume":"9","author":"Webster","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0365","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.sleep.2006.05.011","article-title":"Restless legs syndrome augmentation associated with tramadol","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0370","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.59.10.1573","article-title":"Treatment of restless legs syndrome with gabapentin. A double-blind, cross-over study","volume":"59","author":"Garcia-Borreguero","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2010.07.007_b0375","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/ajkd.2001.25202","article-title":"A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients","volume":"38","author":"Thorp","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sleep.2010.07.007_b0380","first-page":"A294","article-title":"Effective treatment of idiopathic restless legs syndrome with pregabalin: a twelve-week, double-blind, placebo-controlled study with clinical and polysomnographic assessment","volume":"32","author":"Garcia-Borreguero","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0385","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/WNF.0b013e3181b3ab16","article-title":"Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial","volume":"32","author":"Walters","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2010.07.007_b0390","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S0317167100036350","article-title":"The treatment of the restless legs syndrome with clonazepam: a prospective controlled study","volume":"13","author":"Boghen","year":"1986","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.sleep.2010.07.007_b0395","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0404.1984.tb07826.x","article-title":"Clonazepam and vibration in restless legs syndrome","volume":"69","author":"Montagna","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.sleep.2010.07.007_b0400","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5664\/jcsm.27605","article-title":"Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem","volume":"5","author":"Hoque","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0405","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000008138","article-title":"A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome","volume":"43","author":"Davis","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0410","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.sleep.2008.11.003","article-title":"Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study","volume":"10","author":"Wang","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0415","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.sleep.2007.12.006","article-title":"A randomized, double-blind, placebo-controlled trail of intravenous iron sucrose in restless legs syndrome","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0420","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2010.07.007_b0425","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000052098","article-title":"Restless legs syndrome: a clinical study of 55 patients","volume":"45","author":"Bassetti","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.sleep.2010.07.007_b0430","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","article-title":"Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study","volume":"5","author":"Hening","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0435","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.sleep.2005.03.008","article-title":"Prevalence, severity and risk factors of restless legs symdrome in the general adult population in two Scandinavian countries","volume":"6","author":"Bjorvatn","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0440","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.sleep.2006.11.015","article-title":"Comorbidity in restless legs syndrome among a sample of Swedish adults","volume":"8","author":"Ulfberg","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0445","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1819.2008.01825.x","article-title":"Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden","volume":"62","author":"Broman","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.sleep.2010.07.007_b0450","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S1389-9457(02)00147-8","article-title":"EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls","volume":"3","author":"Saletu","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0455","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/sleep\/30.7.861","article-title":"Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study","volume":"30","author":"Hornyak","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0460","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/sleep\/32.6.772","article-title":"Polysomnographic and health-related quality of life correlates of restless legs syndrome in the sleep heart health study","volume":"32","author":"Winkelman","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2010.07.007_b0465","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1097-4679(198901)45:1<51::AID-JCLP2270450107>3.0.CO;2-H","article-title":"Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients","volume":"45","author":"Mosko","year":"1989","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.sleep.2010.07.007_b0470","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1389-9457(00)00023-X","article-title":"Restless legs syndrome in 218 patients: associated disorders","volume":"1","author":"Banno","year":"2000","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0475","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1389-9457(03)00059-5","article-title":"Sleep disorders and depressive feelings: a global survey with the Beck depression scale","volume":"4","author":"Vandeputte","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2010.07.007_b0480","first-page":"226","article-title":"Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey","volume":"75","author":"Sevim","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2010.07.007_b0485","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/jnp.2008.20.1.101","article-title":"Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community","volume":"20","author":"Lee","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994571000290X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138994571000290X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:08:54Z","timestamp":1761404934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138994571000290X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S138994571000290X"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2010.07.007","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restless legs syndrome: Understanding its consequences and the need for better treatment","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2010.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}